novo nordisk semaglutide fda US says two more doses of Nordisk's weight-loss drug now available FDA Warns Novo Nordisk of

Magnetic solid-phase extraction with Fe(3)O(4)/molecularly imprinted polymers modified by deep eutectic solvents and ionic liquids for the rapid purification of alkaloid isomers (Theobromine and Theophylline) from Green Tea

To date, the only dose-specified, comparator, inclusive study between patients with obesity with and without a history of MBS, was conducted in 2024 26

Clinical impact: Weight loss plus improvements in cholesterol, blood pressure, and triglycerides

How does each one work

Healthy Fats: Sustained GLP-1 Through Bile Acid Signaling Dietary fats trigger GLP-1 release through multiple pathways direct activation of fatty acid receptors on L-cells (GPR40 and GPR120), and indirectly through bile acid signaling via the TGR5 receptor

This is primarily driven by weight loss and improved insulin sensitivity